Vanguard Group Inc. Has $608.87 Million Holdings in Sabra Healthcare REIT, Inc. (NASDAQ:SBRA)

Vanguard Group Inc. trimmed its stake in shares of Sabra Healthcare REIT, Inc. (NASDAQ:SBRA - Free Report) by 0.4% during the first quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 34,852,559 shares of the real estate investment trust's stock after selling 138,597 shares during the quarter. Vanguard Group Inc. owned about 14.65% of Sabra Healthcare REIT worth $608,874,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other hedge funds and other institutional investors have also made changes to their positions in the business. UMB Bank n.a. increased its position in shares of Sabra Healthcare REIT by 379.6% in the first quarter. UMB Bank n.a. now owns 2,048 shares of the real estate investment trust's stock worth $36,000 after acquiring an additional 1,621 shares in the last quarter. Assetmark Inc. increased its position in shares of Sabra Healthcare REIT by 37.8% in the first quarter. Assetmark Inc. now owns 3,607 shares of the real estate investment trust's stock worth $63,000 after acquiring an additional 989 shares in the last quarter. Fifth Third Bancorp increased its position in shares of Sabra Healthcare REIT by 110.3% in the first quarter. Fifth Third Bancorp now owns 3,835 shares of the real estate investment trust's stock worth $67,000 after acquiring an additional 2,011 shares in the last quarter. GF Fund Management CO. LTD. purchased a new position in shares of Sabra Healthcare REIT in the fourth quarter worth approximately $74,000. Finally, Harbor Capital Advisors Inc. grew its position in Sabra Healthcare REIT by 17.2% during the first quarter. Harbor Capital Advisors Inc. now owns 4,377 shares of the real estate investment trust's stock valued at $76,000 after purchasing an additional 642 shares in the last quarter. 99.40% of the stock is currently owned by institutional investors.

Insider Transactions at Sabra Healthcare REIT

In other news, Director Michael J. Foster sold 11,000 shares of Sabra Healthcare REIT stock in a transaction on Tuesday, May 20th. The stock was sold at an average price of $18.22, for a total transaction of $200,420.00. Following the completion of the sale, the director owned 64,725 shares of the company's stock, valued at approximately $1,179,289.50. This trade represents a 14.53% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. 1.20% of the stock is owned by corporate insiders.

Sabra Healthcare REIT Trading Up 0.1%

Sabra Healthcare REIT stock traded up $0.01 during trading hours on Friday, reaching $18.46. 2,862,912 shares of the company's stock traded hands, compared to its average volume of 2,604,435. The company has a debt-to-equity ratio of 0.91, a quick ratio of 4.80 and a current ratio of 4.80. Sabra Healthcare REIT, Inc. has a fifty-two week low of $15.60 and a fifty-two week high of $20.03. The firm has a market capitalization of $4.43 billion, a price-to-earnings ratio of 24.29, a PEG ratio of 1.53 and a beta of 0.86. The firm's 50 day moving average is $18.33 and its 200-day moving average is $17.61.

Sabra Healthcare REIT (NASDAQ:SBRA - Get Free Report) last released its earnings results on Monday, August 4th. The real estate investment trust reported $0.38 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $0.36 by $0.02. Sabra Healthcare REIT had a net margin of 24.87% and a return on equity of 6.69%. The company had revenue of $189.15 million for the quarter, compared to the consensus estimate of $185.64 million. During the same period in the prior year, the company posted $0.36 EPS. The company's revenue was up 7.4% compared to the same quarter last year. On average, analysts predict that Sabra Healthcare REIT, Inc. will post 1.45 earnings per share for the current year.

Sabra Healthcare REIT Announces Dividend

The firm also recently declared a quarterly dividend, which will be paid on Friday, August 29th. Shareholders of record on Friday, August 15th will be issued a dividend of $0.30 per share. The ex-dividend date of this dividend is Friday, August 15th. This represents a $1.20 annualized dividend and a yield of 6.5%. Sabra Healthcare REIT's dividend payout ratio (DPR) is currently 157.89%.

Analysts Set New Price Targets

A number of brokerages recently commented on SBRA. JMP Securities boosted their price objective on shares of Sabra Healthcare REIT from $20.00 to $22.00 and gave the company a "market outperform" rating in a research report on Wednesday, August 6th. Scotiabank boosted their price target on shares of Sabra Healthcare REIT from $19.00 to $20.00 and gave the company a "sector perform" rating in a report on Monday, June 23rd. Three analysts have rated the stock with a hold rating, three have given a buy rating and one has assigned a strong buy rating to the stock. Based on data from MarketBeat.com, the stock currently has a consensus rating of "Moderate Buy" and an average price target of $20.00.

Sabra Healthcare REIT Company Profile

Sabra Health Care REIT, Inc engages in the business of acquiring, financing, and owning real estate property. The company was founded on May 10, 2010 and is headquartered in Tustin, CA.